FABP4 and colorectal carcinoma: FABP-4 was not associated with CRC risk in men in either the multivariable-adjusted model (RR per SD in FABP-4 1.07, 95% CI 0.92, 1.23) or the multivariable-adjusted model including body size (0.95, 95% CI 0.80, 1.13).